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Background
 Eight cases identified, represent 23.5% of the 34 crewmembers flown 
on the ISS, with inflight visual changes and pre-to-postflight refractive 
changes. In some cases, the changes were transient while in others 
they are persistent with varying degrees of visual impairment.
• Decreased intraocular pressure (IOP) postflight was observed in 3 cases.
• Fundoscopic exams revealed postflight findings of choroidal folds in 4 
cases, optic disc edema in 5 cases and presence of cotton wool spots in 3 
cases. 
• Optical coherence tomography (OCT) confirmed findings of choroidal folds 
and disc edema and documented retinal nerve fiber layer thickening (4 
cases). 
• Findings from MRI examinations showed posterior globe flattening (5 
cases) and optic nerve sheath distension (6 cases). 
• Opening cerebrospinal fluid (CSF) pressure was elevated in 4 cases 
postflight reflecting raised intracranial pressure.  
 While the etiology remains unknown, hypotheses speculate that 
venous insufficiency or hypertension in the brain caused by cephalad 
fluid shifts during spaceflight are possible mechanisms for ocular 
changes in astronauts.
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Risk Background – Ocular Symptoms
• 8 cases identified (23.5% of 34 long duration crew) with 
inflight visual changes and pre-to-postflight refractive changes. 
• Elevated Intracranial Pressure measured postflight
MRI Orbital 
Image 
showing 
globe 
flattening 
Normal Flattened
Choroidal Folds
parallel grooves in 
the posterior pole
Globe Flattening 
Optic Disc Edema (swelling) 
Vision distortion 
Cotton “wool” spots 
Hyperopic Shifts
Up to +1.75 diopters 
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Cephalad Fluid Shift
5
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Hydrostatic Pressure Changes
Rowell, 1988.
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Venous Pressure & ICP Increases in 
Microgravity-Supine Model
ICP=11.9 mmHgICP=3.9 mmHg
X
X
Internal Jugular 
Vein Caliber
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Increased Volume=Increased Pressure
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MRI Brain Venogram
P Venous 
Risk Background – Intracranial Pressure
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CHOROIDAL FOLDS
•Choroidal folds are parallel grooves or striae that 
involve the choroid in the posterior pole. 
•They are usually horizontal but may be vertical, 
oblique, or irregular and are usually situated 
temporally, rarely extending beyond the 
equator.
•Their characteristic appearance on funduscopic 
examination, with the crests appearing yellow 
and less pigmented, is caused by the stretching 
and thinning of the retinal pigment epithelium, 
and the troughs appearing darker are caused by 
retinal pigment epithelium compression. 
•Known causes of choroidal folds include orbital 
diseases or tumors, choroidal tumors, posterior 
scleritis, hypotony, chronic papilledema or optic 
nerve tumor, choroidal neovascular membrane, 
scleral buckle, and central serous
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The Choroid
11
The choroid contains a dense vascular network 
terminating with the fenestrated choriocapillaris
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Case Report 1: Pre & Post Flight Fundoscopy
[Top Pre Flight] 
Fundoscopic images of the right 
and left posterior pole. 
[Bottom Post Flight]
Fundoscopic images of the right 
and left posterior pole showing 
choroidal folds below the optic 
disc (top arrow) and a“ cotton-
‐wool” spot (bottom arrow) in 
the inferior arcade in the right 
eye. 
Optic disc imaging did not show 
presence of observable disc 
edema.
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Case Report 3: Pre & Post Flight Fundoscopy
[Top Pre Flight] 
Fundoscopic images of the right 
and left optic disc. 
[Bottom Post Flight]
Fundoscopic images of the right 
and left optic disc showing Grade 
3 edema at the right optic disc 
and Grade 1 edema at the left 
optic disc. Fig. 
Pre Flight
OD
Pre Flight
OD
OS
OS
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Case Report 5 - Continued
[Left] Pre flight Zeiss Cirrus OCT showing right and left NFL ‘TSNIT’ (temporal, superior, nasal, inferior and temporal 
curve).
[Right] Post flight Zeiss Cirrus OCT showing increased thickness of the nasal (red arrow) NFL. Greater increase is noted 
in the right eye in the nasal quadrant NFL thickness; 42μ pre flight to 70μ post flight. Fundus and optic disc imaging 
did not show presence of observable disc edema-choroidal folds may be an early sign of elevated ICP which precedes 
papilledema (important to obtain accurate in flight measurement of choroidal fold development-OCT)
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PanOptic Ophthalmoscope
Page No. 16
Raised Intracranial Pressure-Qualitative 
Measurement?
16
Elevated ICP 
transmitted to 
optic nerve
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Cross -Sectional Area of Optic Nerve 
and Sheath
 Optic nerve x-section (post-mortem) from  patient with papilledema. 
 Large space, filled with web-like strands of arachnoid between nerve & nerve 
sheath. 
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Ocular Sonography
 Image optic nerve and nerve sheath with ultrasound
 Optic nerve sheath diameter (ONSD)  ICP
 Gives broad sense of increased ICP versus normal
 No reliable linear relationship
Kimberly HH, Shah S, Marill K, Noble V. Correlation of optic 
nerve sheath diameter with direct measurement of 
intracranial pressure. Acad Emerg Med 2008;15:201-4.
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In Flight B-scan Ultrasound
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Optic Nerve Sheath Diameter
 Generally accepted that ONSD > 5 mm ≈ ICP > 20 cm H2O 
Geeraerts T, Merceron S, Benhamou D, Vigue B, Duranteau J. Non-invasive assessment of intracranial pressure using ocular 
sonography in neurocritical care patients. Intensive Care Med 2008;34:2062-7.
Page No. 21
Case Report 4 - Increased Optic Nerve Sheath Diameter 
On-Orbit
OD OS
12 mm
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Case Report 5: MRI Globe Imaging
T1 MRI orbital imaging of the right eye. Pre flight 
(left) and Post flight (right) showing flattening of 
the posterior globe. 
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CASE Report 4 - Flattening of Posterior Wall – and Raised 
Optic Disk
CONFIDENTIAL
Elevation of optic 
disc
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Ocular Venous Hypertension via Optic 
Nerve Compression
A. Normal distal optic nerve/sheath complex & 
head in longitudinal cross section
B. Papilledema showing enlargement of subarachnoid 
space & compression central retinal vein (CV)
Increasing ICP transmitted to optic         
nerve via CSF space causes 
compression of central retinal vein 
Arterial blood continues to flow into 
eye but venous drainage impaired 
Result= venous hypertension, optic 
disc edema, disc protrusion, globe 
flattening & retinal engorgement, 
hemorrhage etc.
V-vitreous
D-Disc
Sc-sclera
C-Choroid
A-Arachnoid space
S-Optic nerve sheath
N-Optic Nerve
CV-Central retinal vein
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Measurement of Intraocular Pressure 
with Applantation Tonometry
Dr. Story Musgrave conducting tonometry on STS 44
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Elevated ICP-Is it Transmitted to the Eye?
MRI Brain Venogram
P Venous Sinus
P 
P 
Also transmitted to eye 
via ophthalmic veins
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Impacts
 Elevated intracranial pressure and vision disturbance in spaceflight 
are serious health risks to the astronaut population.  
 Much longer missions are being planned that will subject personnel to 
even greater periods of microgravity and hence prolonged exposure to 
elevated IOP and/or ICP. 
 VIIP Risk team formed with membership from Med Ops and HRP.
 Current plan for HRP content is to work via project team within HHC. 
 High-level research plan in development
What are the physiological causes?
Dr. Otto   7 April 2011
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VIIP Risk – Med Ops and Research
 Summit held February 8-10 with national and international experts in 
ophthalmology, neuro-ophthalmology, neurosurgery, neurophysiology, 
and cardiology. 
• Obtained suggestions for current pre, in, and post-flight operations as well 
as research areas with respect to detection, monitoring, treatment, 
imaging, susceptibility, computer modeling, and/or use of analogs. 
 Results from the summit further reinforced the existence of multiple 
contributing factors with no clear cause identified. While Medical 
Operations approaches from a clinical perspective, research is 
needed to further quantify and mitigate the risk.
 The NASA HRP has added this risk to its portfolio and established the 
VIIP Project within the Human Health Countermeasures Element.
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Glaucoma
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Posterior Eye & Optic Nerve Anatomy
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The Lamina Cribosa: Barrier Between 
the Intraocular Space and SAS
The LC serves as a barrier to separate the intraorbital space, with typically higher pressure, from the subarachnopid 
space, with typically lower pressure. The LC therefore prevents orbital contents from leaking into the subarachnoid space
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Lamina Cribosa Structure
• LC is a series of cribiform plates, with pores that line up to permit  nerve axons to pass through
• LC cores are filled with fibrillar collagen and elastic fibres, during aging constituents are altered
• LC   becomes stiffer  and thinner, thus ability to support nerve axons passing though is compromised 
especially around the ages of 40-50 years
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Myopes put Greater Shear Stress on LC 
Higher Risk for Glaucomatous Changes
Stress on any part of ocular shell related to IOP and radius of structure: =PR/2t
=circumferential stress
P=IOP
R=radius of curvature at that part of the globe
T=thickness
Thus, in myopic eyes when LC is cupped, radius is larger, and stress is greater
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Lamina Cribosa: Normal vs Myopic
Normal Eye Myopic Eye
• Shear stresses are dominant, and maximal at the periphery owing to the greater curvature in myopic eye
• LC increases in stiffness with age=decreased compliance’ means higher likelihood of permanent deformation 
and at  lower pressures
• Change in mechanical compliance most marked after 40-50 years of age, same age incidence of glaucoma 
increases. 
•Any elevation in deformation pressure, even transient, may result in permanent shape 
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Key Brain Areas
CSF Production
CSF Resorbtion
Venous Congestion
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CSF Production: Choroid Plexus
Increased filtration?
Choroid plexus in lateral, third & 
fourth ventricle produces 70-90% of 
CSF in brain
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Choroidal Cell Responses in 
Microgravity-Atrial Naturietic Peptide
 ANP neurohormone
 In CNS when ANP activated, decreases CSF by inhibiting Na-K-
ATPase proteins in cerebral capillaries
 Increased ANP binding sites 1.5-2.5x in HLU rat studies 
Immunodetection of (red) Na-K-ATPase at the apical pole of choroid plexus
(B) in a control rat         (D) in a ground-based model simulating cephalad fluid shift 
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Gabrion et al. Choroidal responses in microgravity.  Acta Astronautica. 1995  
Normal  Control Choroid Cell
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Choroidal Cell Responses in Microgravity-
Aquaporin-1 Expression
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Immunodetection of aquaporin 1 (in 
green) at the apical pole of choroid 
plexus,
(A) in a control rat (homogeneously 
covered with long bulbous apical 
microvilli, and tufts of kinocillia) 
(C) in a model simulating cephalad fluid 
shift. AQP1 was reduced 64% after 
14d spaceflight (STS-58), by 44% 
after 14 days HLU, and by 68% 
after 28d HLU. 
A net decrease was noted at the 
epithelial cells, suggesting that CSF
production was decreased.
Loss of microvilli, failure of exocytosis, 
loss of kinocillia
Suggests brain adaptation in 
microgravity with a reduction in CSF 
secretory activity.
Normal  Control Choroid Cell
Abnormal  0G Analog  Choroid Cell
Gabrion et al. Choroidal responses in microgravity.  Acta Astronautica. 1995  
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Overshoot of AQP-1: A Mechanism for 
Elevated ICP Post Flight?
 Once rats returned to 1G, at 2 days readaptation, AQP1 expression 
was 48% greater than control rats 
 In the 14d HLU rats there was a 57% increased expression in AQP-
1 after 6 hours readaptation, compared to controls
 Could over-expression of AQP-1 upon return to 1G be a mechanism 
for the persistently elevated ICP seen in some crew members?
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Flow analysis of CSF through the 
aqueduct
• The flow analysis of CSF through the aqueduct (axial 
oblique section noted as dashed line --Bottom). 
• A CINE phase contrast sequence obtained 
perpendicular to the mid cerebral aqueduct showing 
velocity versus time after the QRS wave (graph --‐ top 
left) Case #5:
• R+30: CSF production rate=305 ul/min
• CSF peak velocity=3.65cm/s
• R+57: LP opening pressure=28.5
• R+180:CSF production rate=682 ul/min
• CSF peak velocity=7.80cm/s
• Normal CSF production 150-270 ul/min
• Cross sectional image through the mid cerebral 
aqueduct (Middle) showing the area of flow analysis
• T1 weighted mid sagittal image (Bottom) showing 
plane of section through the mid cerebral aqueduct
• There is no obvious narrowing of the cerebral 
aqueduct. CSF production rate is approximately one 
standard deviation above average in several cases
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Normal CSF Diffusion Gradient
ICP= 10mmHg
Venous Sinus Pressure=5-7mmHg
Normal SSVP:CSFP= 0.60
Therefore delta driving pressure only~3-5mmHg
Page No. 43
MRI Brain Venogram
P Venous 
Risk Background – Intracranial Pressure
As SSVP:CSFP increases, approaches 1.0
Driving pressure falls<3-5mmHg and decreased CSF absorbtion
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CSF Resorption: 
Arachnoid Granulations
Electron micrograph of outer arachnoid granulation-
apical region- showing collagen fibers surrounding 
the pores and linking the granulations
Electron Micrograph of clustered arachnoid granulations from the 
floor of the superior sagital sinus. Arrows pointing to lobules
Inflammation of the arachnoid villi as 
one mechanism inhibiting resorption?
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Blocked Lymphatic Drainage of CSF
Perineural pathways along 
cranial nerves for 
subarachnoid CSF-
lymphatic connections  may 
become congested 
decreasing absorbtion
(thin curved arrows)
Low pressure system
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Exacerbating Factors?
Strength training may cause 
potentially damaging transient 
spikes in ICP
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Carbon Dioxide
Normal Sea Level CO2=0.0314%
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CO2 on ISS
 CO2 level mission average=3.56mmHg (0.33%)
• Ten times normal atmospheric
• (Normal sea level atmospheric CO2=0.0314%)
 No mission under 2.0mmHg
 Average Peak CO2=8.32mmHg (0.7%)
 CO2 potent vasodilator
 Cerebral CO2 autoregulation not changed in microgravity.
1
 Causes increased blood flow
• Every 1mmHg increase PaCO2=4% increase in cerebrovascular dilation
• Problem-cerebral blood vessels are already congested
• Thought to be contributory to the symptoms occurring at lower 
levels.
• Causes increased CSF production.
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Compliance: Intracranial 
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CO2 Symptoms in Space
 Symptom onset 1.3-1.6mmHg
 Primarily noted to be headache and visual changes.
 When CO2 level dropped headaches dissipate 
 Noted onset at levels far lower than terrestrially i.e. 
 Mission Control personnel noticed behavioral changes had occurred 
at lower levels in crewmembers. Procedural errors, unwarranted 
comments from crewmembers, and increased “aggravation”
 EVA crewmembers “felt better” post initiation of Oxygen pre-breath 
and donning the suit (100% O2 and 4.3 psi environment).
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Pre-Flight MRID 1.10 (L-180 – L-30)
All Long Duration crew members 
 Refraction
 Near and far visual acuity
 Tonometry
 Automated visual fields
 Dilated Fundoscopy
 Contact lens/spectacle storage plan
 Amsler Grid
 Retinal photography
 Extraoccular muscle examination
 Spectral domain optical coherence tomography 
(OCT)
 Pupil reflex
 Biomicroscopy
 A-Scan Ultrasound
• PanOptic video 
fundoscopy baseline 
and training
• 3T orbital MRI with 
contrast
• 2-D imaging ultrasound 
baseline and training 
Previous Additional
Red = currently performed as per existing MRID
Blue = currently performed, but are added to new MRID
Page No. 52
In-Flight MRID 1.10 (L+30, R-30, L+100)
All Long Duration crew members 
 None previously required per MRID L+30 and R-30, potentially at L+100
• Near and far visual acuity
• Amsler grid
• Questionnaire
• Tonometry
• Dilated PanOptic video 
fundoscopy exam
• Remotely guided HRF eye 
ultrasound
Previous Additional
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Post-Flight MRID 1.10 (R+ 0- R+3 or ASAP)
All Long Duration crew members 
 Near and far visual acuity
 Tonometry
 Pupil reflex
 Extraoccular muscle examination
 Biomicroscopy
 Questionnaire
 Amsler Grid
 Dilated Fundoscopic exam
 Automated visual fields
 Refraction
 Retinal photography
 Spectral domain optical coherence tomography (OCT)
 A-Scan Ultrasound
• 3T orbital MRI with 
contrast
• 2-D imaging 
ultrasound
Previous Additional
Red = currently performed as per existing MRID
Blue = currently performed, but are added to new MRID
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Visual Impairment and Intracranial 
Pressure Flow Chart
Page No. 55
Hypothesized Mechanisms of Cerebral Blood Flow 
Autoregulation Inflight and Postflight for Asymptomatic and 
Symptomatic Crewmembers
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VIIP Knowledge Gaps
 Gaps (VIIP1) What is the etiology of visual acuity and ocular structural and 
functional changes seen in-flight and post-flight? 
 Gap (VIIP2) Does exposure to microgravity cause changes in visual acuity, 
intraocular pressure and/or intracranial pressure?  Are the effects related to 
mission duration? 
 Gap (VIIP3) What in-flight diagnostic tools are needed to measure changes in 
intraocular pressure and intracranial pressure?  
 Gap (VIIP4) Are changes in visual acuity related to changes in chronic 
choroidal engorgement, elevated intraocular pressure  and/or intracranial 
pressure? Gap
 (VIIP5) Do multiple or cumulative exposures to spaceflight increase the risk of 
changes in visual acuity, intraocular pressure or intracranial pressure? 
 Gap (VIIP6) How do changes in vascular compliance/pressures influence 
intraocular pressure or intracranial pressure?  
 Gap (VIIP7) Is intracranial hypertension and visual impairment an all or 
nothing phenomenon or a continuum of severity that occurs in all individuals 
during spaceflight? 
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VIIP Knowledge Gaps
 Gap (VIIP8) What is the role of the ISS environment (e.g. high salt diet, CO2
pockets, pharmaceutical use, exercise countermeasures) on ocular structure 
and function and intracranial pressure? 
 Gap (VIIP9) What is the time course for recovery of intracranial hypertension 
and visual impairment and do anatomical structures of the eye recover? What 
factors determine the rate of recovery? 
 Gap (VIIP10) Are asymptomatic crewmembers with anatomic eye changes or 
low grade intracranial hypertension at risk for future visual impairments? 
 Gap (VIIP11) Does long-term, low grade intracranial hypertension predispose 
individuals to disease processes other than what manifests in the eye?
 Gap (VIIP12) Are there suitable ground-based analogs to study this 
spaceflight-associated phenomenon? 
 Gap (VIIP13) Can safe and effective countermeasures be designed (in-flight 
and post-flight) to mitigate changes in visual acuity, intraocular pressure and 
intracranial hypertension if a problem it exists? 
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Forward Research-Possible 
Countermeasures: Braslet
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Russian-US ISS Braslet Study
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Femoral Vein Images with and without Braslet 
Applied
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Internal Jugular Vein vs Breathing 
Manouvers With & Without Braslet
Internal jugular vein cross sections with and without Braslet applied, with breathing maneuvers: 
With Braslet application the internal jugular vein responds to Valsalva with smaller changes, and 
with Mueller maneuver the vein almost completely collapses. 
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Combining Countermeasures?
Aerobic exercise may be 
protective as it draws 
cephalad fluid caudally into 
lower limbs
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Countermeasures for Arterial and
Venous Circuits?
Rat Basilar Artery:
A. Control 
B. 14d Hindlimb 
Unloaded
Cerebral artery 
Hypertrophies with
Cephald fluid shift
Braslet good for sequestering 
venous volume on lower limb 
venous capacitance vessels
Braslet  DOES NOT prevent 
upper body arterial circuit from 
seeing elevated pressures, nor 
lower body arteries  from seeing  
decreased pressures.
Is there an additional technology 
that could assist?
Rat Hindlimb Skeletal Artery:
A. Control 
B. 14d Hindlimb  Unloaded
Hindlimb skeletal artery  artrophies 
with Cephald fluid shift
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Chibis LBNP Device
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Chibis LBNP Device
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VIIP Project Structure
Clinical
Epidemiology/
Data Mining
Diagnostic 
Monitoring 
Technology 
Risk 
Identification
Analog 
Development 
Countermeasure 
(CM) 
Development 
iVIIP
Research/Clinical 
Advisory Panel
rVIIPoVIIP 
Data we have –
but requires 
analysis
Data we need to 
acquire -
clinical/research
Development  
of additional 
hardware 
required to 
obtain new 
data
Analogs required to 
enable understanding 
of VIIP and testing of 
CMs
Clinical 
Practice 
Guidelines
CPGs
Risk Mitigation
Research
Shared  Med 
Ops/Research
Med Ops
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Compliance: Vascular 
Preliminary review of data for affected crew members reveals that blood pressure, serum lipids and 
homocysteine may be elevated compared to those non-affected. Also, maximal aerobic oxygen 
uptake may be lower in those affected.
Page No. 68
Exercise Protective?
L-90/45 daysAcceptable up 
to L-365 days
Ultrasound
Eye/Orbit
MRI
Of Brain and Orbits 
Without Contrast
Fundoscopy
- PanOptic
Ophthalmoscope
Tonometry
Visual 
Acuity
Including Amsler
Grid Testing
Other  
Tests -
biomicroscopy (slit 
lamp), high 
resolution retinal 
photography, OCT 
(high resolution), and 
A-Scan. 
Preflight Exams
Ultrasound
Eye/Orbit
MRI
Of Brain and Orbits 
Without Contrast
Fundoscopy
- PanOptic
Ophthalmoscope
Tonometry
Visual 
Acuity
Including Amsler
Grid TestingOther  
Tests -
biomicroscopy (slit 
lamp), high 
resolution retinal 
photography, OCT 
(high resolution), and 
A-Scan. 
Ultrasound
Eye/Orbit
Fundoscopy
- PanOptic
Ophthalmoscope
Tonometry
Visual 
Acuity
Including Amsler
Grid Testing
L+30 & R-30, 
L+100 if requested 
(+/- 7 days) & 
as clinically indicated
In-flight Exams Post flight Exams
L+30 L+100 R-30L-90/45L-365
R+1 to R+3 
(or as soon as possible)
R+1 to R+3 
Proposed Pre/In/Post-Flight VIIP Research Testing
L+60L+10
Ultrasound
Eye/Orbit
Fundoscopy
- PanOptic
Ophthalmoscope
Tonometry
Visual 
Acuity
Including Amsler
Grid Testing
Blood 
Pressure
Vascular 
Compliance
L+10, 30, 60, 100 
& R-30, 
(+/- 7 days)
Vascular 
Compliance
Vascular 
Compliance
R+90 R+30 
R+30 
R+180 R+365 
New Tests for 
consideration
Page No. 70
Proposed In-Flight VIIP Data Collection 
Sequence Per Increment Time Point
Data Collection Per Increment Time Point
(L+10, L+30, L+60, L+100, L-30)
Day 1 Time Day 2 or 3 Time
Data Collection Measures
ManualCuff BP 7min ManualCuff BP 7 min
Visual Acuity 5 min Visual Acuity 5 min
Amsler Grid 5 min Amsler Grid 5 min
PanOptic Retinal Imaging 45 min IOP Tonometry 20 min
ManualCuff BP 7 min
Cardiac Echo measures 5 min
Ocular Ultrasound 35 min
Total Time: 1:02 Hours Total Time: 1:24
Real-time Guidance
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VIIP Schedule Summary
71
2011 2012 2013 2014 2015 2016 2017 2018 2019Fiscal Year
Shuttle & ISS Retire Shuttle ISS End of US Commitment
2020
Research Content of Evidence Book and RMAT
Data Mining
Inputs to Project-Level Plan/Dev of Sub-Project Plan
Research Content of TBD Plan
Support  Est. Adv. Panel/Rvw Schedule
Develop Standard Measures
Feasibility Assessments
TBD Hardware Developments
Animal Studies/Model Validation
Validate HDT Bed Rest Model
TBD Countermeasure Development
Pre-, In-, Post-flight Monitoring of Visual Health
In-Flight Measures (Risk Characterization)
Fluid Loading and Distribution Studies
TBD Countermeasure Dev/Validation
NOTE: Products iterative over time pending 
Research/Med Ops results. Schedule 
indicates planned completion of first drafts 
and some key dependencies.
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VIIP Risk – Research Approach
Conduct data mining;
Compile evidence base
Develop 
research plan
Monitor visual health via crewmember annual physical 
Med Ops
HRP
Inflight monitoring of visual health
Data sharing
Identify and obtain 
additional measures
Identify and validate 
analogs
Develop and validate 
countermeasures
Utilize internal and external experts to:
• Develop plan
• Complete tasks
• Review and assess progress 
Conduct research to 
characterize risk
Complete technology 
development
Research/Clinical 
Advisory Panel
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 Ocular Findings
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 Current Methodologies
 Cases
 Contributing Structures of the Eye
 CSF Production
 CSF Resorption
 Exacerbating Factors
 Current Measures
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 Opportunities for Partnership
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Informational Briefing:
Risk of Microgravity-Induced Visual Impairment 
and Elevated Intracranial Pressure (VIIP)
Wednesday May 25, 2011.
Christian Otto, M.D., VIIP Project Scientist
